Prevention of neural tube defects: results of the Medical Research Council vitamin study. MRC Vitamin Study Research Group. Lancet. 1991, 338 (8760): 131-7. 10.1016/0140-6736(91)90133-A.
Czeizel AE, Dudάs I: Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992, 327 (26): 1832-5.
Article
CAS
PubMed
Google Scholar
Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM: Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet. 1995, 346: 393-6. 10.1016/S0140-6736(95)92778-6.
Article
CAS
PubMed
Google Scholar
Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ: Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet. 1995, 59: 536-45. 10.1002/ajmg.1320590428.
Article
CAS
PubMed
Google Scholar
Botto LD, Mulinare J, Erickson JD: Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol. 2000, 151 (9): 878-84.
Article
CAS
PubMed
Google Scholar
Czeizel AE, Tüth M, Rockenbauer M: Population-based case-control study of folic acid supplementation during pregnancy. Teratology. 1996, 53 (6): 345-51. 10.1002/(SICI)1096-9926(199606)53:6<345::AID-TERA5>3.0.CO;2-Z.
Article
CAS
PubMed
Google Scholar
Werler MM, Hayes C, Louik C, Shapiro S, Mitchell AA: Multivitamin supplementation and risk of birth defects. Am J Epidemiol. 1999, 150 (7): 675-82.
Article
CAS
PubMed
Google Scholar
Loffredo LC, Souza JM, Freitas JA, Mossey PA: Oral clefts and vitamin supplementation. Cleft Palate Craniofac J. 2001, 38 (1): 76-83. 10.1597/1545-1569(2001)038<0076:OCAVS>2.0.CO;2.
Article
CAS
PubMed
Google Scholar
Itikala PR, Watkins ML, Mulinare J, Moore CA, Liu Y: Maternal multivitamin use and orofacial clefts in offspring. Teratology. 2001, 63 (2): 79-86. 10.1002/1096-9926(200102)63:2<79::AID-TERA1013>3.0.CO;2-3.
Article
CAS
PubMed
Google Scholar
Czeizel AE: Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet. 1996, 62 (2): 179-83. 10.1002/(SICI)1096-8628(19960315)62:2<179::AID-AJMG12>3.0.CO;2-L.
Article
CAS
PubMed
Google Scholar
Czeizel AE, Dobó M, Vargha P: Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol. 2004, 70 (11): 853-61. 10.1002/bdra.20086.
Article
CAS
PubMed
Google Scholar
Put van der NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, Heuvel van den LP, Mariman EC, den Heyer M, Rozen R, Blom HJ: Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995, 346 (8982): 1070-1. 10.1016/S0140-6736(95)91743-8.
Article
PubMed
Google Scholar
Put van der NM, Heuvel van den LP, Steegers-Theunissen RP, Trijbels FJ, Eskes TK, Mariman EC, den Heyer M, Blom HJ: Decreased methylene tetrahydrofolate reductase activity due to the 677C-->T mutation in families with spina bifida offspring. J Mol Med. 1996, 74 (11): 691-4. 10.1007/s001090050073.
Article
PubMed
Google Scholar
Kirke PN, Mills JL, Whitehead AS, Molloy A, Scott JM: Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet. 1996, 348 (9033): 1037-8. 10.1016/S0140-6736(05)64971-9.
Article
CAS
PubMed
Google Scholar
Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ: Maternal vitamin use, genetic variations of infant methylene tetrahydrofolate reductase and risk for spina bifida. Am J Epidemiol. 1998, 148 (1): 30-7.
Article
CAS
PubMed
Google Scholar
Posey DL, Khoury MJ, Mulinare J, Admas MJ, Ou CY: Is mutated MTHFR a risk factor for neural tube defects?. Lancet. 1996, 347 (9002): 686-7. 10.1016/S0140-6736(96)91236-2.
Article
CAS
PubMed
Google Scholar
Botto LD, Yang Q: 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000, 151 (9): 862-77.
Article
CAS
PubMed
Google Scholar
Junker R, Kotthoff S, Vielhaber H, Halimeh S, Kosch A, Koch HG, Kassenböhmer R, Heineking B, Nowak-Göttl U: Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovas Res. 2001, 51 (2): 251-4. 10.1016/S0008-6363(01)00286-3.
Article
CAS
Google Scholar
Wenstrom KD, Johanning GL, Johnston KE, DuBard M: Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol. 2001, 184 (5): 806-17. 10.1067/mob.2001.113845.
Article
CAS
PubMed
Google Scholar
Croen LA, Shaw GM, Jensvold NJ, Harris JA: Birth defects monitoring in California: a resource for epidemiological research. Paediatr Perinat Epidemiol. 1991, 5 (4): 423-7. 10.1111/j.1365-3016.1991.tb00728.x.
Article
CAS
PubMed
Google Scholar
Schulman J, Hahn JA: Quality control of birth defects registry data: a case study. Publ Health Rep. 1993, 108 (1): 91-8.
CAS
Google Scholar
Lovmar L, Syvänen AC: Multiple displacement amplification to create a long-lasting source of DNA for genetic studies. Hum Mutat. 2006, 27 (1): 603-14. 10.1002/humu.20341.
Article
CAS
PubMed
Google Scholar
Holbrook JF, Stabley D, Sol-Church K: Exploring whole genome amplification as a DNA recovery tool for molecular genetic studies. J Biomol Tech. 2005, 16 (2): 125-33.
PubMed
PubMed Central
Google Scholar
Bergen AW, Qi Y, Haque KA, Welch RA, Chanock SJ: Effects of DNA mass on multiple displacement whole genome amplification and genotyping performance. BMC Biotechnol. 2005, 5: 24-10.1186/1472-6750-5-24.
Article
PubMed
PubMed Central
Google Scholar
Fredicksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J: Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Human Mut. 2007, 28 (9): 856-65. 10.1002/humu.20522.
Article
Google Scholar
Piedrahita JA, Oetma B, Bennett GD, van Waes J, Kamen BA, Richardson J, Lacey SW, Anderson RG, Finnell RH: Mice lacking the folic-acid binding protein Folbp1 are defective in early embryonic development. Nat Genet. 1999, 23 (2): 228-32. 10.1038/13861.
Article
CAS
PubMed
Google Scholar
Linden van der IJ, Afman LA, Heil SG, Blom HJ: Genetic variation in genes of folate metabolism and neural-tube defect risk. Proc Nutr Soc. 2006, 65 (2): 204-15.
Article
PubMed
Google Scholar
Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, Bassuk AG, Kessler JA, Reed MC, Nijhout HF, George TM, Enterline DS, Gilbert JR, Speer MC, NTD Collaborative Group: Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ Health Perspect. 2006, 114 (10): 1547-52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hobbs CA, James SJ, Parsian A, Krakowiak PA, Jerrigan S, Greenhaw JJ, Lu Y, Cleves MA: Congenital heart defects and genetic variants in the methylenetetrahydrofolate reductase gene. J Med Genet. 2006, 43 (2): 162-6. 10.1136/jmg.2005.032656.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shaw GM, Iovannisci DM, Yang W, Finnell RH, Carmichael SL, Cheng S, Lammer EJ: Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet A. 2005, 138 (1): 21-6.
Article
PubMed
Google Scholar
Storti S, Vittorini S, Lascone MR, Sacchelli M, Collavoli A, Ripoli A, Cocchi G, Biagini A, Clerico A: Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. Clin Chem Lab Med. 2003, 41 (3): 276-80. 10.1515/CCLM.2003.043.
Article
CAS
PubMed
Google Scholar
Deng L, Elmore CL, Lawrance AK, Matthews RG, Rozen R: Methionine synthase reductase deficiency results in adverse reproductive outcomes and congenital heart defects in mice. Mol Genet Metab. 2008, 94 (3): 336-42. 10.1016/j.ymgme.2008.03.004.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhu H, Wicker NJ, Shaw GM, Lammer EJ, Hendricks K, Suarez L, Canfield M, Finnell RH: Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab. 2003, 78 (3): 216-21. 10.1016/S1096-7192(03)00008-8.
Article
CAS
PubMed
Google Scholar
Doolin MT, Barbaux S, McDonnell M, Hoess K, Whitehead AS, Mitchell LE: Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet. 2002, 71 (5): 1222-6. 10.1086/344209.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guçant-Rodriguez RM, Rendeli C, Namour B, Venuti L, Romano A, Anello G, Bosco P, Debard R, Gçrard P, Viola M, Salvaggio E, Guçant JL: Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett. 2003, 344 (3): 189-92. 10.1016/S0304-3940(03)00468-3.
Article
Google Scholar
De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Finnell RH, Zhu H, Andreussi L, Cama A, Capra V: Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet. 2002, 47 (6): 319-24. 10.1007/s100380200043.
Article
CAS
PubMed
Google Scholar
O'Leary VB, Mills JL, Pangilinan F, Kirke PN, Cox C, Conley M, Weiler A, Peng K, Shane B, Scott JM, Parle-McDermott A, Molly AM, Brody LC, Members of the Birth Defects Research Group: Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol Genet Metab. 2005, 85 (3): 220-7. 10.1016/j.ymgme.2005.02.003.
Article
PubMed
Google Scholar
Banerjee R, Zou CG: Redox regulation and reaction mechanism of human cystathionine-B-synthase: a PLP-dependent hemesensor protein. Arch Biochem Biophys. 2005, 433 (1): 144-56. 10.1016/j.abb.2004.08.037.
Article
CAS
PubMed
Google Scholar
Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, Gravel RA, Rozen R: A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab. 1999, 67 (4): 317-23. 10.1006/mgme.1999.2879.
Article
CAS
PubMed
Google Scholar
Candito M, Rivet R, Herbeth B, Boisson C, Rudigoz RC, Luton D, Journel H, Oury JF, Rouv F, Saura R, Vernhet I, Gaucherand P, Muller F, Guidicelli B, Heckenroth H, Poulain P, Blayau M, Francannet C, Roszy KL, Brustiç C, Staccini P, Gçrard P, Fillion-Emery N, Guçant-Rodriguez RM, Van Obberghen E, Guçant JL: Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: a multicenter case-control study. Am J Med Genet Part A. 2008, 146A (9): 1128-33. 10.1002/ajmg.a.32199.
Article
CAS
PubMed
Google Scholar
Relton CL, Wilding CS, Laffling AJ, Jonas PA, Burgess T, Binks K, Tawn EJ, Burn J: Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metabol. 2004, 81 (4): 273-81. 10.1016/j.ymgme.2003.12.010.
Article
CAS
Google Scholar
van Beynum IM, Kouwenberg M, Kapusta L, den Heijer M, Linden van der IJ, Daniels O, Blom HJ: MTRR 66A>G polymorphism in relation to congenital heart defects. Clin Chem Lab Med. 2006, 44 (11): 1317-23. 10.1515/CCLM.2006.254.
Article
CAS
PubMed
Google Scholar
Verkleij-Hagoort AC, van Driel LM, Lindemans J, Isaacs A, Steegers EA, Helbing WA, Uitterlinden AG, Steegers-Theunissen RP: Genetic lifestyle factors related to the periconception vitamin B12 status and congenital heart defects: a Dutch case-control study. Mol Genet Metab. 2008, 94 (1): 112-9. 10.1016/j.ymgme.2007.12.002.
Article
CAS
PubMed
Google Scholar
Parle-McDermott A, Kirke PN, Mills JL, Molloy AM, Cox C, O'Leary VB, Pangilinan F, Conley M, Cleary L, Brody LC, Scott JM: Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur J Hum Genet. 2006, 14 (6): 768-72. 10.1038/sj.ejhg.5201603.
Article
CAS
PubMed
Google Scholar
De Marco P, Merello E, Calevo MG, Mascelli S, Raso A, Cama A, Capra V: Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958>A polymorphism for neural tube defect risk. J Hum Genet. 2006, 51 (2): 98-103. 10.1007/s10038-005-0329-6.
Article
PubMed
Google Scholar
Johnson WG, Stenroos ES, Spychala JR, Chatkupt S, Ming SX, Buyske S: New 19 bp deletion polymorphism in Intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy?. Am J Med Genet A. 2004, 124A (4): 339-45. 10.1002/ajmg.a.20505.
Article
PubMed
Google Scholar
Parle-McDermott A, Pangilinan F, Mills JL, Kirke PN, Gibney ER, Troendle J, O'Leary VB, Molloy AM, Conley M, Scott JM, Brody LC: The 19-bp deletion polymorphism in Intron-1 of dihyrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population. Am J Med Genet A. 2007, 143A (11): 1174-80. 10.1002/ajmg.a.31725.
Article
CAS
PubMed
Google Scholar
Linden van der IJ, Nguyen U, Heil SG, Franke B, Vloet S, Gellekink H, den Heijer M, Blom HJ: Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. Mol Genet Met. 2007, 91 (1): 98-103. 10.1016/j.ymgme.2007.01.009.
Article
Google Scholar
Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH: Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet. 2002, 108 (1): 1-6. 10.1002/ajmg.10195.
Article
PubMed
Google Scholar
Shaw GM, Zhu H, Lamer EJ, Yang W, Finnell RH: Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects. Am J Epidemiol. 2003, 158 (8): 747-52. 10.1093/aje/kwg189.
Article
PubMed
Google Scholar
Pei L, Zhu H, Ren A, Li Z, Hao L, Finnell RH, Li Z: Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population. Birth Defects Res A Clin Mol Teratol. 2005, 73 (6): 430-3. 10.1002/bdra.20130.
Article
CAS
PubMed
Google Scholar
Pei L, Zhu H, Zhu J, Ren A, Finnell RH, Li Z: Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial defects and congenital heart defects in China. Ann Epidemiol. 2006, 16 (5): 352-6. 10.1016/j.annepidem.2005.02.014.
Article
PubMed
Google Scholar
De Marco P, Calevo MG, Moroni A, Merello E, Raso A, Finnell RH, Zhu H, Andreussi L, Cama A, Capra V: Reduced folate carrier polymorphism (80A-->G) and neural tube defects. Eur J Hum Genet. 2003, 11 (3): 245-52. 10.1038/sj.ejhg.5200946.
Article
CAS
PubMed
Google Scholar
Trinh BN, Ong CN, Coetzee GA, Yu MC, Laird PW: Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet. 2002, 111 (3): 299-302. 10.1007/s00439-002-0779-2.
Article
CAS
PubMed
Google Scholar
Wilding CS, Relton CL, Sutton MJ, Jonas PA, Lynch SA, Tawn EJ, Burn J: Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the Northern United Kingdom. Birth Def Res A Clin Mol Teratol. 2004, 70 (7): 483-5. 10.1002/bdra.20038.
Article
CAS
Google Scholar
Volcik KA, Shaw GM, Zhu H, Lammer EJ, Laurent C, Finnell RH: Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Res A Clin Mol Teratol. 2003, 67 (11): 924-8. 10.1002/bdra.10029.
Article
CAS
PubMed
Google Scholar
Liu J, Schmitz JC, Lin X, Tai N, Yan W, Farrell M, Bailly M, Chen T, Chu E: Thymidylate synthase as a translational regulator of cellular gene expression. Biochim Biophys Acta. 2002, 1587 (2–3): 174-82.
Article
CAS
PubMed
Google Scholar
Kawate H, Landis DM, Loeb LA: Distribution of mutations in human thymidylate synthase yielding resistance to 5-fluorodeoxyuridine. J Biol Chem. 2002, 277 (39): 36304-11. 10.1074/jbc.M204956200.
Article
CAS
PubMed
Google Scholar
Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD: Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res. 2002, 62 (12): 3361-4.
CAS
PubMed
Google Scholar
Thomas DC, Witte JS: Point: population stratification: a problem for case-control studies of candidate-gene associations?. Cancer Epidemiol Biomarkers Prev. 2002, 11 (6): 505-12.
PubMed
Google Scholar
Wacholder S, Rothman N, Caporaso N: Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev. 2002, 11 (6): 513-20.
PubMed
Google Scholar